{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T01:29:26Z","timestamp":1780882166590,"version":"3.54.1"},"reference-count":35,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1136\/jnnp-2012-304332","type":"journal-article","created":{"date-parts":[[2013,3,6]],"date-time":"2013-03-06T02:22:20Z","timestamp":1362536540000},"page":"1199-1205","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":55,"title":["Changes to anti-JCV antibody levels in a Swedish national MS cohort"],"prefix":"10.1136","volume":"84","author":[{"given":"Clemens","family":"Warnke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Ramanujam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Plavina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Goelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Subramanyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Kockum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar","family":"Rahbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernd C","family":"Kieseier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Holm\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hillert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Fogdell-Hahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2013,3,5]]},"reference":[{"key":"key-10.1136\/jnnp-2012-304332-1","doi-asserted-by":"crossref","first-page":"5909","DOI":"10.4049\/jimmunol.0803418","article-title":"Cutting edge: natalizumab blocks adhesion but not initial contact of human T cells to the blood-brain barrier in vivo in an animal model of multiple sclerosis","volume":"182","author":"Coisne","year":"2009","journal-title":"J Immunol"},{"key":"key-10.1136\/jnnp-2012-304332-2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1212\/01.WNL.0000158329.30470.D0","article-title":"Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale","volume":"64","author":"Rice","year":"2005","journal-title":"Neurology"},{"key":"key-10.1136\/jnnp-2012-304332-3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","article-title":"Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases","volume":"9","author":"Clifford","year":"2010","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","article-title":"Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring","volume":"10","author":"Kappos","year":"2011","journal-title":"Lancet Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-5","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","article-title":"Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy","volume":"354","author":"Yousry","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2012-304332-6","doi-asserted-by":"crossref","first-page":"e1000368","DOI":"10.1371\/journal.pgen.1000368","article-title":"Adaptive mutations in the JC virus protein capsid are associated with progressive multifocal leukoencephalopathy (PML)","volume":"5","author":"Sunyaev","year":"2009","journal-title":"PLoS Genet"},{"key":"key-10.1136\/jnnp-2012-304332-7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/infdis\/jir198","article-title":"Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity","volume":"204","author":"Gorelik","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.1136\/jnnp-2012-304332-8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/infdis\/jir256","article-title":"Sequencing and analysis of JC virus DNA from natalizumab-treated PML patients","volume":"204","author":"Reid","year":"2011","journal-title":"J Infect Dis"},{"key":"key-10.1136\/jnnp-2012-304332-9","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1001\/archneurol.2010.161","article-title":"Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?","volume":"67","author":"Warnke","year":"2010","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ana.22128","article-title":"Anti-JC virus antibodies: implications for PML risk stratification","volume":"68","author":"Gorelik","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-11","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/ana.22304","article-title":"Assay design and sample collection can affect anti-John Cunningham virus antibody detection","volume":"69","author":"Goelz","year":"2011","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-12","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","article-title":"Risk of natalizumab-associated progressive multifocal leukoencephalopathy","volume":"366","author":"Bloomgren","year":"2012","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2012-304332-13","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00115-011-3319-2","article-title":"Risk stratification of progressive multifocal leukoencephalopathy under natalizumab: recommendations for JC virus serology","volume":"82","author":"Warnke","year":"2011","journal-title":"Nervenarzt"},{"key":"key-10.1136\/jnnp-2012-304332-14","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ana.22606","article-title":"Anti-John Cunnigham virus antibody prevalence in multiple sclerosis patients: baseline results of STRATIFY-1","volume":"70","author":"Bozic","year":"2011","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jcv.2011.10.003","article-title":"Multi-site analytical validation of an assay to detect anti-JCV antibodies in human serum and plasma","volume":"53","author":"Plavina","year":"2012","journal-title":"J Clin Virol"},{"key":"key-10.1136\/jnnp-2012-304332-16","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/1352458510394701","article-title":"A Swedish national post-marketing surveillance study of natalizumab treatment in multiple sclerosis","volume":"17","author":"Holmen","year":"2011","journal-title":"Mult Scler"},{"issue":"Suppl 3","key":"key-10.1136\/jnnp-2012-304332-17","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s10072-010-0345-y","article-title":"Swedish natalizumab (Tysabri) multiple sclerosis surveillance study","volume":"31","author":"Piehl","year":"2011","journal-title":"Neurol Sci"},{"key":"key-10.1136\/jnnp-2012-304332-18","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1128\/jcm.5.6.629-634.1977","article-title":"Solid-phase enzyme immunoassay for immunoglobulin M antibodies to cytomegalovirus","volume":"5","author":"Schmitz","year":"1977","journal-title":"J Clin Microbiol"},{"key":"key-10.1136\/jnnp-2012-304332-19","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1128\/CVI.05061-11","article-title":"Varicella-Zoster Virus (VZV) Glycoprotein E Is a Serological Antigen for Detection of Intrathecal Antibodies to VZV in Central Nervous System Infections, without Cross-Reaction to Herpes Simplex Virus 1","volume":"18","author":"Grahn","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"key-10.1136\/jnnp-2012-304332-20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jviromet.2011.04.014","article-title":"Recombinant glycoprotein E produced in mammalian cells in large-scale as an antigen for varicella-zoster-virus serology","volume":"175","author":"Thomsson","year":"2011","journal-title":"J Virol Methods"},{"key":"key-10.1136\/jnnp-2012-304332-21","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/jmv.10450","article-title":"Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40","volume":"71","author":"Knowles","year":"2003","journal-title":"J Med Virol"},{"key":"key-10.1136\/jnnp-2012-304332-22","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"key":"key-10.1136\/jnnp-2012-304332-23","doi-asserted-by":"crossref","first-page":"M93","DOI":"10.1136\/mp.48.2.M93","article-title":"Differential expression of cell adhesion molecules in the functional compartments of lymph nodes and tonsils","volume":"48","author":"Leite","year":"1995","journal-title":"Clin Mol Pathol"},{"key":"key-10.1136\/jnnp-2012-304332-24","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1182\/blood-2007-09-112052","article-title":"Increased numbers of circulating hematopoietic stem\/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab","volume":"111","author":"Bonig","year":"2008","journal-title":"Blood"},{"key":"key-10.1136\/jnnp-2012-304332-25","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/bmt.2009.381","article-title":"CD49d blockade by natalizumab in patients with multiple sclerosis affects steady-state hematopoiesis and mobilizes progenitors with a distinct phenotype and function","volume":"45","author":"Jing","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"key-10.1136\/jnnp-2012-304332-26","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1001\/archneurol.2011.238","article-title":"Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors","volume":"68","author":"Saure","year":"2011","journal-title":"Arch Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/1352458510385834","article-title":"CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus","volume":"17","author":"Warnke","year":"2011","journal-title":"Mult Scler"},{"key":"key-10.1136\/jnnp-2012-304332-28","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.1182\/blood-2007-10-120329","article-title":"The monoclonal anti-VLA-4 antibody natalizumab mobilizes CD34+ hematopoietic progenitor cells in humans","volume":"111","author":"Zohren","year":"2008","journal-title":"Blood"},{"key":"key-10.1136\/jnnp-2012-304332-29","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/eji.201142108","article-title":"Natalizumab Treatment Perturbs Memory- and Marginal Zone-like B-cell Homing in Secondary Lymphoid Organs in Multiple Sclerosis","volume":"42","author":"Planas","year":"2011","journal-title":"Eur J Immunol"},{"key":"key-10.1136\/jnnp-2012-304332-30","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.4049\/jimmunol.152.8.3760","article-title":"Adhesion through the LFA-1 (CD11a\/CD18)-ICAM-1 (CD54) and the VLA-4 (CD49d)-VCAM-1 (CD106) pathways prevents apoptosis of germinal center B cells","volume":"152","author":"Koopman","year":"1994","journal-title":"J Immunol"},{"key":"key-10.1136\/jnnp-2012-304332-31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00912.x","article-title":"Mechanisms that determine plasma cell lifespan and the duration of humoral immunity","volume":"236","author":"Amanna","year":"2010","journal-title":"Immunol Rev"},{"key":"key-10.1136\/jnnp-2012-304332-32","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1699-0463.1993.tb00206.x","article-title":"Serum antibodies to viral pathogens and Toxoplasma gondii in HIV-infected individuals","volume":"101","author":"Flo","year":"1993","journal-title":"Apmis"},{"key":"key-10.1136\/jnnp-2012-304332-33","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.4049\/jimmunol.0902890","article-title":"Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status","volume":"184","author":"Vescovini","year":"2010","journal-title":"J Immunol"},{"key":"key-10.1136\/jnnp-2012-304332-34","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/ana.22137","article-title":"JC virus persistence following progressive multifocal leukoencephalopathy in multiple sclerosis patients treated with natalizumab","volume":"68","author":"Ryschkewitsch","year":"2010","journal-title":"Ann Neurol"},{"key":"key-10.1136\/jnnp-2012-304332-35","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0b013e3182583022","article-title":"Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort","volume":"78","author":"Trampe","year":"2012","journal-title":"Neurology"}],"container-title":["Journal of Neurology, Neurosurgery & Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2012-304332","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,29]],"date-time":"2023-06-29T23:18:47Z","timestamp":1688080727000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2012-304332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,5]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2013,10,9]]},"published-print":{"date-parts":[[2013,11]]}},"alternative-id":["10.1136\/jnnp-2012-304332"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2012-304332","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,5]]}}}